MIF associated with pulmonary hypertension susceptibility and severity in non-dialysis Chronic kidney disease patients
Pulmonary hypertension (PAH) is one of the more serious complications of Chronic kidney disease (CKD), and its exact pathogenesis has not been clarified. As an upstream proinflammatory factor, macrophage migration inhibitor (MIF) is involved in the occurrence and development of many diseases. This s...
Main Authors: | Jianhua Wu, Naifeng Guo, Xiaolan Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-10-01
|
Series: | European Journal of Inflammation |
Online Access: | https://doi.org/10.1177/2058739220961191 |
Similar Items
-
Prevalence of pulmonary hypertension in patients with chronic kidney disease on and without dialysis
by: Magdy M. Emara, et al.
Published: (2013-10-01) -
Pulmonary hypertension in patients with chronic kidney disease on dialysis and without dialysis: results of the PEPPER-study.
by: Stefan Pabst, et al.
Published: (2012-01-01) -
Blood pressure management in hypertensive people with non-dialysis chronic kidney disease in Queensland, Australia
by: Jianzhen Zhang, et al.
Published: (2019-09-01) -
Bone biomarkers help grading severity of coronary calcifications in non dialysis chronic kidney disease patients.
by: Marion Morena, et al.
Published: (2012-01-01) -
Macrophage inhibitory factor (MIF) gene polymorphisms are associated with disease susceptibility and with circulating MIF levels in active non‐segmental vitiligo in patients from western Mexico
by: Alejandra Garcia‐Orozco, et al.
Published: (2020-10-01)